Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.96% |
| 2 | Healthcare | 15.73% |
| 3 | Financials | 11.78% |
| 4 | Industrials | 11.76% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Welltower
WELL
$173B
| $16.5M | 0.03% |
171,883
-1,264
| -0.7% | -$110K |
|
|
SNV
602
DELISTED
Synovus
SNV
| $16.5M | 0.03% |
336,035
+88,567
| +36% | +$4.48M |
|
603
OneMain Financial
OMF
$7.23B
| $16.4M | 0.03% |
345,194
-66,253
| -16% | -$3.3M |
|
604
NNN REIT
NNN
$8.89B
| $16.3M | 0.03% |
362,161
-20,243
| -5% | -$891K |
|
605
Analog Devices
ADI
$181B
| $16.2M | 0.03% |
98,018
-144,794
| -60% | -$23.5M |
|
606
Zimmer Biomet
ZBH
$19.3B
| $16.2M | 0.03% |
126,455
-6,984
| -5% | -$842K |
|
607
Belden
BDC
$4.56B
| $16.1M | 0.03% |
290,991
+184,761
| +174% | +$10.6M |
|
608
Polaris
PII
$3.66B
| $16M | 0.03% |
151,938
-11,301
| -7% | -$1.29M |
|
609
XPO
XPO
$22.5B
| $16M | 0.03% |
368,967
+19,977
| +6% | +$835K |
|
610
Power Integrations
POWI
$2.97B
| $15.9M | 0.03% |
172,006
+131,443
| +324% | +$11.5M |
|
611
Stanley Black & Decker
SWK
$14.9B
| $15.9M | 0.03% |
113,814
-107,238
| -49% | -$17.7M |
|
612
Aramark
ARMK
$15.6B
| $15.5M | 0.03% |
569,732
-4,742
| -0.8% | -$124K |
|
613
Xerox
XRX
$374M
| $15.4M | 0.03% |
764,529
-325,439
| -30% | -$6.84M |
|
614
BOK Financial
BOKF
$8.54B
| $15.4M | 0.03% |
163,422
-5,761
| -3% | -$595K |
|
615
Wintrust Financial
WTFC
$10.3B
| $15.3M | 0.03% |
164,862
+886
| +0.5% | +$86.3K |
|
616
LPL Financial
LPLA
$28.7B
| $15.2M | 0.03% |
83,042
+39,366
| +90% | +$6.86M |
|
617
Hewlett Packard
HPE
$69.4B
| $15.1M | 0.03% |
903,675
-76,678
| -8% | -$1.29M |
|
618
Deckers Outdoor
DECK
$12.5B
| $15.1M | 0.03% |
330,048
-20,040
| -6% | -$994K |
|
619
Illumina
ILMN
$33.7B
| $15M | 0.03% |
44,173
-42,965
| -49% | -$14.5M |
|
620
Pool Corp
POOL
$6.84B
| $14.9M | 0.03% |
35,326
+11,221
| +47% | +$5.24M |
|
621
Northern Trust
NTRS
$34.2B
| $14.9M | 0.03% |
128,092
-79,820
| -38% | -$9.46M |
|
622
Valero Energy
VLO
$99.6B
| $14.8M | 0.03% |
145,272
+130,826
| +906% | +$11.3M |
|
|
ONC
623
BeOne Medicines Ltd
ONC
$42.1B
| $14.7M | 0.03% |
77,952
-729
| -0.9% | -$155K |
|
|
SKX
624
DELISTED
Skechers
SKX
| $14.6M | 0.03% |
358,280
-6,076
| -2% | -$260K |
|
|
PINC
625
DELISTED
Premier
PINC
| $14.5M | 0.03% |
407,537
+250,398
| +159% | +$9.32M |
|
Similar funds
Cliff Asness's Q1 2022 Portfolio in Review
As of Q1 2022, Cliff Asness held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Cliff Asness's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Cliff Asness's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- Cliff Asness added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- Cliff Asness's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- Cliff Asness fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- Cliff Asness's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- Cliff Asness opened 187 new positions and closed 158 in Q1 2022.
- Cliff Asness's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.